Cetuximab-Induced Acneiform Eruption: A Case Report

Authors : Büşra Güner, Türkkan Evrensel, Sibel Oyucu Orhan

Pages : 117-119

Doi:10.46310/tjim.1071185

View : 31 | Download : 12

Publication Date : 2022-04-01

Article Type : Other

Abstract :Epidermal growth factor receptor (EGFR) monoclonal antibody inhibitors are used to treat metastatic colorectal cancers. Cetuximab, an EGFR inhibitor drug, targets specific molecular pathways and does not cause the severe systemic side effects seen in cytotoxic chemotherapy. Herein, we presented a case who developed acneiform eruptions during cetuximab treatment.
Keywords : CETUXIMAB, ACNEIFORM ERUPTION, metastatic colorectal cancer, K-ras